Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0000950170-24-001195

Options or other derivatives

  • Director acquired 191,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hogue Dale Curtis Jr. Director 2023-12-29 Grant or award · Employee Stock Option (right to buy) +150,000 150,000 D: show line 1 in the form
Hogue Dale Curtis Jr. Director 2023-12-29 Grant or award · Employee Stock Option (right to buy) +41,667 41,667 D: show line 2 in the form
Loading xslF345X05/ownership.xml…